An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14656566.2023.2178898
PubMed Identifier: 36946625
Publication URI: http://europepmc.org/abstract/MED/36946625
Type: Journal Article/Review
Volume: 24
Parent Publication: Expert opinion on pharmacotherapy
Issue: 4
ISSN: 1465-6566